Mitochondrial biogenesis is the process by which cells increase their individual mitochondrial mass and copy number to increase the production of ATP as a response to greater energy expenditure. It was first described by John Holloszy in the 1960s, when it was discovered that physical endurance training induced higher mitochondrial content levels, leading to greater glucose uptake by muscles. Mitochondrial biogenesis is activated by numerous different signals during times of cellular stress or in response to environmental stimuli, such as aerobic exercise.
The ability for a mitochondrion to self-replicate is rooted in its evolutionary history. As mitochondria are known to be descendants from cells that formed endosymbiotic relationships with α-protobacteria, they have their own genome for replication. The mitochondrion is a key regulator of the metabolic activity of the cell, and is also an important organelle in both production and degradation of free radicals. It is presumed that higher mitochondrial copy number (or higher mitochondrial mass) is protective for the cell.
Mitochondria are produced from the transcription and translation of genes both in the nuclear genome and in the mitochondrial genome. The majority of mitochondrial protein comes from the nuclear genome, while the mitochondrial genome encodes parts of the electron transport chain along with mitochondrial rRNA and tRNA. Mitochondrial biogenesis increases metabolic enzymes for glycolysis, oxidative phosphorylation and ultimately a greater mitochondrial metabolic capacity. However, depending on the energy substrates available and the REDOX state of the cell, the cell may increase or decrease the number and size of mitochondria. Critically, mitochondrial numbers and morphology vary according to cell type and context-specific demand, whereby the balance between mitochondrial fusion/fission regulates mitochondrial distribution, morphology, and function.
Mitochondrial proteins encoded from the nuclear genome need to be targeted and transported appropriately into the mitochondria. Since the majority of mitochondrial protein comes from the nuclear genome, the proteins need to be properly targeted and transported into the mitochondria to perform their functions. First, mRNA is translated in the cell’s cytosol. The resulting unfolded precursor proteins will then be able to reach their respective mitochondrial compartments. Precursor proteins will be transported to one of four areas of the mitochondria, which include the outer membrane, inner membrane, intermembrane space, and matrix. All proteins will enter the mitochondria by a translocase on the outer mitochondrial membrane (TOM). Some proteins will have an N-terminal targeting signal, and these proteins will be detected and transported into the matrix, where they will then be cleaved and folded. Other proteins may have targeting information in their sequences and will not include an N-terminal signal. During the past two decades, researchers have discovered over thirty proteins that participate in mitochondrial protein import. As researchers learn more about these proteins and how they reach the respective mitochondrial compartments that utilize them, it becomes evident that there is a multitude of processes that work together in the cell to allow for mitochondrial biogenesis.
Fusion and fission
Mitochondria are highly versatile and are able to change their shape through fission and fusion events. Definitively, fission is the event of a single entity breaking apart, whereas fusion is the event of two or more entities joining to form a whole. The processes of fission and fusion oppose each other and allow the mitochondrial network to constantly remodel itself. If a stimulus induces a change in the balance of fission and fusion in a cell, it could significantly alter the mitochondrial network. For example, an increase in mitochondrial fission would create many fragmented mitochondria, which has been shown to be useful for eliminating damaged mitochondria and for creating smaller mitochondria for efficient transporting to energy-demanding areas. Therefore, achieving a balance between these mechanisms allow a cell to have the proper organization of its mitochondrial network during biogenesis and may have an important role in muscle adaptation to physiological stress.
The processes of fusion and fission allow for mitochondrial reorganization.
In mammals, mitochondrial fusion and fission are both controlled by GTPases of the dynamin family. The process of mitochondrial fission is directed by Drp1, a member of the cytosolic dynamin family. This protein forms a spiral around mitochondria and constricts to break apart both the outer and inner membranes of the organelle. On the other hand, the process of fusion is directed by different membrane-anchored dynamin proteins at different levels of the mitochondria. Fusion at the level of the outer mitochondrial membrane is mediated by Mfn1 and Mfn2 (Mitofusins 1 and 2), and fusion at the level of the inner mitochondrial membrane is mediated by Opa1. Multiple research studies have observed correlated increases between mitochondrial respiratory capacity with Mfn1, Mnf2, and Drp1 gene expression after endurance exercises. Therefore, it is supported that reorganization of the mitochondrial network in muscle cells plays an important role in response to exercise.
PGC-1α, a member of the peroxisome proliferator-activated receptor gamma (PGC) family of transcriptional coactivators, is the master regulator of mitochondrial biogenesis. It is known to co-activate nuclear respiratory factor 2 (NRF2/GABPA), and together with NRF-2 coactivates nuclear respiratory factor 1 (NRF1). The NRFs, in turn, activate the mitochondrial transcription factor A (tfam), which is directly responsible for transcribing nuclear-encoded mitochondrial proteins. This includes both structural mitochondrial proteins as well as those involved in mtDNA transcription, translation, and repair. PGC- 1β, a protein that is structurally similar to PGC-1α, is also involved in regulating mitochondrial biogenesis, but differs in that it does not get increased in response to exercise. While there have been significant increases in mitochondria found in tissues where PGC-1α is overexpressed, as the cofactor interacts with these key transcription factors, knockout mice with disrupted PGC-1α are still viable and show normal mitochondrial abundance. Thus, PGC-1α is not required for normal development of mitochondria in mice, but when put under physiological stress, these mice exhibit diminished tolerance compared to mice with normal levels of PGC-1α. Similarly, in knockout mice with disrupted PGC-1β, the mice showed mostly normal levels of mitochondrial function with decreased ability to adapt to physiological stress. However, a double knockout experiment of PGC-1α/β created mice that died mostly within 24 hours by defects in mitochondrial maturation of cardiac tissue. These findings suggest that while both PGC-1α and PGC- 1β do not each solely establish a cell’s ability to perform mitochondrial biogenesis, together they are able to complement each other for optimal mitochondrial maturation and function during periods of physiological stress.
AMP-activated kinase (AMPK) also regulates mitochondrial biogenesis by phosphorylating and activating PGC-1α upon sensing an energy deficiency in muscle. In mice with reduced ATP/AMP ratios that would occur during exercise, the energy depletion has been shown to correlate with AMPK activation. AMPK activation then continued to activate PGC- 1α and NRFs in these mice, and mitochondrial biogenesis was stimulated.
The capacity for mitochondrial biogenesis has been shown to decrease with age, and such decreased mitochondrial function has been associated with diabetes and cardiovascular disease. (Source) Aging and disease can induce changes in the expression levels of proteins involved in the fission and fusion mechanisms of mitochondria, thus creating dysfunctional mitochondria. (Source). One hypothesis for the detrimental results of aging is associated with the loss of telomeres, the end segments of chromosomes that protect genetic information from degradation (Source). Telomere loss has also been associated with decreased mitochondrial function. Deficiency of telomerase reverse transcriptase (TERT), an enzyme that plays a role in preserving telomeres, has been correlated with activated p53, a protein that suppresses PGC-1α (Source).Therefore, the loss of telomeres and TERT that comes with aging has been associated with impaired mitochondrial biogenesis. AMPK expression has also been shown to diminish with age, which may also contribute to suppressing mitochondrial biogenesis. (Source)
- (20) Handy, Diane E.; Loscalzo, Joseph (2011-12-06). “Redox Regulation of Mitochondrial Function”. Antioxidants & Redox Signaling. 16 (11): 1323–1367. doi:10.1089/ars.2011.4123. ISSN 1523-0864. PMC . PMID 22146081.
- David, Rachel (2011-04-01). “Ageing: Mitochondria and telomeres come together”. Nature Reviews Molecular Cell Biology. 12 (4): 204–204. doi:10.1038/nrm3082. ISSN 1471-0072.
- Hagen, Tory M.; Wehr, Carol M.; Ames, Bruce N. (1998-11-01). “Mitochondrial Decay in Aging: Reversal through Supplementation of Acetyl-l-Carnitine and N-tert-Butyl-α-phenyl-nitronea”. Annals of the New York Academy of Sciences. 854 (1): 214–223. doi:10.1111/j.1749-6632.1998.tb09904.x. ISSN 1749-6632.
- Sahin, Ergün; Colla, Simona; Liesa, Marc; Moslehi, Javid; Müller, Florian L.; Guo, Mira; Cooper, Marcus; Kotton, Darrell; Fabian, Attila J. (2011-02-17). “Telomere dysfunction induces metabolic and mitochondrial compromise”. Nature. 470 (7334): 359–365. doi:10.1038/nature09787. ISSN 1476-4687. PMC . PMID 21307849.
- Sahin, Ergün; DePinho, Ronald A. (2012-05-16). “Axis of ageing: telomeres, p53 and mitochondria”. Nature Reviews Molecular Cell Biology. 13(6): 397–404. doi:10.1038/nrm3352. ISSN 1471-0072. PMC . PMID 22588366.
Reference & Precision Notes
^ Jump up to: a b c Valero T (2014). “Mitochondrial biogenesis: pharmacological approaches”. Current Pharmaceutical Design. 20 (35): 5507–9. doi:10.2174/138161282035140911142118. PMID 24606795.
^ Jump up to: a b c Sanchis-Gomar F, García-Giménez JL, Gómez-Cabrera MC, Pallardó FV (2014). “Mitochondrial biogenesis in health and disease. Molecular and therapeutic approaches”. Current Pharmaceutical Design. 20 (35): 5619–33. doi:10.2174/1381612820666140306095106. PMID 24606801.
Jump up ^ Holloszy, John O. (2011-01-01). Comprehensive Physiology. John Wiley & Sons, Inc. doi:10.1002/cphy.c100052/full. ISBN 9780470650714.
^ Jump up to: a b Boushel R, Lundby C, Qvortrup K, Sahlin K (October 2014). “Mitochondrial plasticity with exercise training and extreme environments”. Exercise and Sport Sciences Reviews. 42 (4): 169–74. doi:10.1249/JES.0000000000000025. PMID 25062000.
Jump up ^ Jornayvaz FR, Shulman GI (2010-01-01). “Regulation of mitochondrial biogenesis”. Essays in Biochemistry. 47: 69–84. doi:10.1042/bse0470069. PMC 3883043 Freely accessible. PMID 20533901.
Jump up ^ Bevilacqua, Lisa; Ramsey, Jon J.; Hagopian, Kevork; Weindruch, Richard; Harper, Mary-Ellen (2004-05-01). “Effects of short- and medium-term calorie restriction on muscle mitochondrial proton leak and reactive oxygen species production”. American Journal of Physiology. Endocrinology and Metabolism. 286 (5): E852–861. doi:10.1152/ajpendo.00367.2003. ISSN 0193-1849. PMID 14736705.
^ Jump up to: a b c d e f g h i j Mishra P, Chan DC (February 2016). “Metabolic regulation of mitochondrial dynamics”. The Journal of Cell Biology. 212 (4): 379–87. doi:10.1083/jcb.201511036. PMC 4754720 Freely accessible. PMID 26858267.
^ Jump up to: a b c d e Bertholet AM, Delerue T, Millet AM, Moulis MF, David C, Daloyau M, Arnauné-Pelloquin L, Davezac N, Mils V, Miquel MC, Rojo M, Belenguer P (June 2016). “Mitochondrial fusion/fission dynamics in neurodegeneration and neuronal plasticity”. Neurobiology of Disease. 90: 3–19. doi:10.1016/j.nbd.2015.10.011. PMID 26494254.
^ Jump up to: a b c d e f g Dudek, Jan; Rehling, Peter; van der Laan, Martin (2013-02-01). “Mitochondrial protein import: Common principles and physiological networks”. Biochimica et Biophysica Acta (BBA) – Molecular Cell Research. Protein Import and Quality Control in Mitochondria and Plastids. 1833 (2): 274–285. doi:10.1016/j.bbamcr.2012.05.028.
^ Jump up to: a b c d e f g h i Baker, Michael J.; Frazier, Ann E.; Gulbis, Jacqueline M.; Ryan, Michael T. (2007-09-01). “Mitochondrial protein-import machinery: correlating structure with function”. Trends in Cell Biology. 17 (9): 456–464. doi:10.1016/j.tcb.2007.07.010. ISSN 1879-3088. PMID 17825565.
^ Jump up to: a b c d e f g h i j Jornayvaz, François R.; Shulman, Gerald I. (2010-01-01). “Regulation of mitochondrial biogenesis”. Essays in biochemistry. 47: 69–84. doi:10.1042/bse0470069. ISSN 0071-1365. PMC 3883043 Freely accessible. PMID 20533901.
^ Jump up to: a b Ventura-Clapier, R.; Garnier, A.; Veksler, V. (2008-07-15). “Transcriptional control of mitochondrial biogenesis: the central role of PGC-1”. Cardiovascular Research. 79 (2): 208–217. doi:10.1093/cvr/cvn098. ISSN 0008-6363.
^ Jump up to: a b c d e f g Youle, Richard J.; Bliek, Alexander M. van der (2012-08-31). “Mitochondrial Fission, Fusion, and Stress”. Science. 337 (6098): 1062–1065. doi:10.1126/science.1219855. ISSN 0036-8075. PMC 4762028 Freely accessible. PMID 22936770.
^ Jump up to: a b c Bo, Hai; Zhang, Yong; Ji, Li Li (2010-07-01). “Redefining the role of mitochondria in exercise: a dynamic remodeling”. Annals of the New York Academy of Sciences. 1201 (1): 121–128. doi:10.1111/j.1749-6632.2010.05618.x. ISSN 1749-6632.
^ Jump up to: a b c d e Cartoni, Romain; Léger, Bertrand; Hock, M. Benjamin; Praz, Manu; Crettenand, Antoinette; Pich, Sara; Ziltener, Jean-Luc; Luthi, François; Dériaz, Olivier (2005-08-15). “Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise”. The Journal of Physiology. 567 (Pt 1): 349–358. doi:10.1113/jphysiol.2005.092031. ISSN 0022-3751. PMC 1474174 Freely accessible. PMID 15961417.
^ Jump up to: a b c d e f g h i j Johri A, Chandra A, Beal MF (September 2013). “PGC-1α, mitochondrial dysfunction, and Huntington’s disease”. Free Radical Biology & Medicine. 62: 37–46. doi:10.1016/j.freeradbiomed.2013.04.016. PMC 3722269 Freely accessible. PMID 23602910.
^ Jump up to: a b c d Lin, Jiandie; Wu, Pei-Hsuan; Tarr, Paul T.; Lindenberg, Katrin S.; St-Pierre, Julie; Zhang, Chen-yu; Mootha, Vamsi K.; Jäger, Sibylle; Vianna, Claudia R. (2004-10-01). “Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice”. Cell. 119 (1): 121–135. doi:10.1016/j.cell.2004.09.013.
^ Jump up to: a b c Scarpulla, Richard C. (2011-07-01). “Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network”. Biochimica et Biophysica Acta (BBA) – Molecular Cell Research. Mitochondria and Cardioprotection. 1813 (7): 1269–1278. doi:10.1016/j.bbamcr.2010.09.019. PMC 3035754 Freely accessible. PMID 20933024.
^ Jump up to: a b Lai, Ling; Leone, Teresa C.; Zechner, Christoph; Schaeffer, Paul J.; Kelly, Sean M.; Flanagan, Daniel P.; Medeiros, Denis M.; Kovacs, Attila; Kelly, Daniel P. (2008-07-15). “Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart”. Genes & Development. 22 (14): 1948–1961. doi:10.1101/gad.1661708. ISSN 0890-9369. PMC 2492740 Freely accessible. PMID 18628400.
Jump up ^ Handy, Diane E.; Loscalzo, Joseph (2011-12-06). “Redox Regulation of Mitochondrial Function”. Antioxidants & Redox Signaling. 16 (11): 1323–1367. doi:10.1089/ars.2011.4123. ISSN 1523-0864. PMC 3324814 Freely accessible. PMID 22146081.
^ Jump up to: a b c d e David, Rachel (2011-04-01). “Ageing: Mitochondria and telomeres come together”. Nature Reviews Molecular Cell Biology. 12 (4): 204–204. doi:10.1038/nrm3082. ISSN 1471-0072.
Jump up ^ Hagen, Tory M.; Wehr, Carol M.; Ames, Bruce N. (1998-11-01). “Mitochondrial Decay in Aging: Reversal through Supplementation of Acetyl-l-Carnitine and N-tert-Butyl-α-phenyl-nitronea”. Annals of the New York Academy of Sciences. 854 (1): 214–223. doi:10.1111/j.1749-6632.1998.tb09904.x. ISSN 1749-6632.
^ Jump up to: a b c Sahin, Ergün; Colla, Simona; Liesa, Marc; Moslehi, Javid; Müller, Florian L.; Guo, Mira; Cooper, Marcus; Kotton, Darrell; Fabian, Attila J. (2011-02-17). “Telomere dysfunction induces metabolic and mitochondrial compromise”. Nature. 470 (7334): 359–365. doi:10.1038/nature09787. ISSN 1476-4687. PMC 3741661 Freely accessible. PMID 21307849.
^ Jump up to: a b c d e f Sahin, Ergün; DePinho, Ronald A. (2012-05-16). “Axis of ageing: telomeres, p53 and mitochondria”. Nature Reviews Molecular Cell Biology. 13 (6): 397–404. doi:10.1038/nrm3352. ISSN 1471-0072. PMC 3718675 Freely accessible. PMID 22588366.
Smith JA, Stallons LJ, Collier JB, Chavin KD, Schnellmann RG (February 2015). “Suppression of mitochondrial biogenesis through toll-like receptor 4-dependent mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling in endotoxin-induced acute kidney injury”. The Journal of Pharmacology and Experimental Therapeutics. 352 (2): 346–57. doi:10.1124/jpet.114.221085. PMC 4293437 Freely accessible. PMID 25503387.
Cameron RB, Beeson CC, Schnellmann RG (December 2016). “Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases”. Journal of Medicinal Chemistry. 59 (23): 10411–10434. doi:10.1021/acs.jmedchem.6b00669. PMC 5564430 Freely accessible. PMID 27560192.
Whitaker RM, Corum D, Beeson CC, Schnellmann RG (2016). “Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases”. Annual Review of Pharmacology and Toxicology. 56: 229–49. doi:10.1146/annurev-pharmtox-010715-103155. PMID 26566156.